ADDED
At February 23, 2026, there were 73,965,939 common shares outstanding, $0.0125 par value per share, of the registrant.
Form 10-K Summary 227 Cautionary Note Regarding Forward-Looking Statements In this Form 10-K, references to "AXIS Capital" refer to AXIS Capital Holdings Limited and references to "we", "us", "our", "AXIS", the "Group" or the "Company" refer to AXIS Capital Holdings Limited and its direct and indirect subsidiaries and branches.
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements.
This Annual Report on Form 10-K or any other written or oral statements made by or on behalf of the Company may include forward-looking statements, which reflect the Company s current views with respect to future events and financial performance.
In some cases, these forward-looking statements can be identified by the use of forward-looking words such as "may", "should", "could", "anticipate", "estimate", "expect", "plan", "believe", "predict", "potential", "aim", "will", "target", "intend" or similar statements of a future or forward-looking nature or their negative or similar terminology.
We may be adversely affected by losses related to the war in Ukraine, tensions in the Middle East, instability in Latin America, terrorism and political unrest, the imposition of tariffs or other trade restrictions and/or unanticipated losses.
Our operations, like those of other insurers and reinsurers, are susceptible to the effects of economic and social inflation because premiums are established before actual losses and loss expenses are known We may be adversely affected by the effects of emerging claims, systemic risks, and coverage issues and/or if actual claims exceed our reserves for losses and loss expenses ("loss reserves").
There are many factors that would cause ultimate loss estimates to increase or decrease, which include, but are not limited to, emerging claims, systemic risks, and coverage issues such as changes in claim severity.
We may be adversely affected by our failure to keep the pace or manage technology developments, including artificial intelligence.
Our underwriting activities may expose us to liquidity risks.
REMOVED
At February 21, 2025, there were 80,786,584 common shares outstanding, $0.0125 par value per share, of the registrant.
All statements, other than statements of historical facts included in this report, including statements regarding our estimates, beliefs, expectations, intentions, strategies or projections are forward-looking statements.
We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the United States ("U.S.") federal securities laws.
In some cases, these statements can be identified by the use of forward-looking words such as "may", "should", "could", "anticipate", "estimate", "expect", "plan", "believe", "predict", "potential", "aim", "will", "target", "intend" or similar expressions.
Forward-looking statements only reflect our expectations and are not guarantees of performance.
These statements involve risks, uncertainties and assumptions.
Accordingly, there are or will be important factors that could cause actual events or results to differ materially from those indicated in such statements.
In this Form 10-K, references to "AXIS Capital" refer to AXIS Capital Holdings Limited and references to "we", "us", "our", "AXIS", the "Group" or the "Company" refer to AXIS Capital Holdings Limited and its direct and indirect subsidiaries and branches.
Summary of Risk Factors Investing in our common stock involves substantial risks, and our ability to successfully operate our business is subject to numerous risks, including those that are generally associated with operating in the insurance and reinsurance industry.
Some of the more significant material challenges and risks include the following: Insurance Risk Insurance risk is the inherent uncertainty as to the occurrence, amount and timing of insurance and reinsurance liabilities transferred to us through the underwriting process.